|
Volumn 20, Issue 14, 2012, Pages 4422-4429
|
Synthesis and evaluation of in vitro bioactivity for vesicular acetylcholine transporter inhibitors containing two carbonyl groups
|
Author keywords
Receptor; CNS disorders; Parkinson's disease; VAChT; Vesamciol
|
Indexed keywords
[1' (4 FLUOROBENZOYL) 4' HYDROXY (1,3' BIPIPERIDIN) 4 YL] (4 METHOXYPHENYL)METHANONE OXALIC ACID;
[1' (4 METHOXYBENZOYL) 4' HYDROXY (1,3' BIPIPERIDIN) 4 YL] (4 METHOXYPHENYL)METHANONE OXALIC ACID;
[1' BENZOYL 4' HYDROXY (1,3' BIPIPERIDIN) 4 YL] (4 FLUOROPHENYL)METHANONE OXALIC ACID;
[1' BENZOYL 4' HYDROXY (1,3' BIPIPERIDIN) 4 YL] (4 METHOXYPHENYL)METHANONE OXALIC ACID;
[3' HYDROXY 1' (5 METHYLTHIOPHENE 2 CARBONYL)(1,4' BIPIPERIDIN) 4 YL] (4 METHOXYPHEYL)METHANONE OXALIC ACID;
[3' HYDROXY 1' (THIOPHENE 2 CARBONYL)(1,4' BIPIPERIDIN) 4 YL] (4 METHOXYPHEYL)METHANONE OXALIC ACID;
[4 (4 FLUOROBENZOYL) 3' HYDROXY [1,4' BIPIPERIDIN] 1' YL] (3 METHYLTHIOPHEN 2 YL)METHANONE OXALIC ACID;
[4 (4 FLUOROBENZOYL) 3' HYDROXY [1,4' BIPIPERIDIN] 1' YL](THIOPHEN 2 YL)METHANONE OXALIC ACID;
[4 (4 FLUOROBENZOYL) 4' HYDROXY (1,3' BIPIPERIDIN) 1' YL] (3 METHYLTHIOPHEN 2 YL)METHANONE OXALIC ACID;
[4 (4 FLUOROBENZOYL) 4' HYDROXY (1,3' BIPIPERIDIN) 1' YL] (4 METHOXYPHENYL)METHANONE OXALIC ACID;
[4 (4 FLUOROBENZOYL) 4' HYDROXY (1,3' BIPIPERIDIN) 1' YL] (5 METHYLTHIOPHEN 2 YL)METHANONE OXALIC ACID;
[4 (4 FLUOROBENZOYL) 4' HYDROXY (1,3' BIPIPERIDIN) 1' YL] (PYRIDIN 3 YL)METHANONE OXALIC ACID;
[4 (4 FLUOROBENZOYL) 4' HYDROXY (1,3' BIPIPERIDIN) 1' YL](THIOPAN 2 YL)METHANONE OXALIC ACID;
[4' HYDROXY (1,3' BIPIPERIDINE) 1',4 DIYL]BIS (4 FLUOROPHENYL)METHANONE OXALIC ACID;
[4' HYDROXY 1' (3 METHYLTHIOPHENE 2 CARBONYL) (1,3' BIPIPERIDIN) 4 YL] (4 METHOXYPHENYL)METHANONE OXALIC ACID;
[4' HYDROXY 1' (THIOPENE 2 CARBONYL) (1,3' BIPIPERIDIN) 4 YL] (4 METHOXYPHENYL)METHANONE OXALIC ACID;
CARBONYL DERIVATIVE;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
UNCLASSIFIED DRUG;
VESAMICOL;
VESICULAR ACETYLCHOLINE TRANSPORTER;
ANIMAL TISSUE;
ARTICLE;
BINDING AFFINITY;
BIOLOGICAL ACTIVITY;
COMPETITIVE INHIBITION;
CONTROLLED STUDY;
DRUG PROTEIN BINDING;
DRUG SCREENING;
DRUG SELECTIVITY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
GUINEA PIG;
HUMAN;
HUMAN CELL;
IC 50;
IN VITRO STUDY;
NONHUMAN;
RAT;
STRUCTURE ACTIVITY RELATION;
AMINES;
CARBON RADIOISOTOPES;
CELL LINE, TUMOR;
FLUORINE RADIOISOTOPES;
HUMANS;
KETONES;
KINETICS;
PIPERIDINES;
POSITRON-EMISSION TOMOGRAPHY;
PROTEIN BINDING;
RADIOPHARMACEUTICALS;
STRUCTURE-ACTIVITY RELATIONSHIP;
VESICULAR ACETYLCHOLINE TRANSPORT PROTEINS;
|
EID: 84863185156
PISSN: 09680896
EISSN: 14643391
Source Type: Journal
DOI: 10.1016/j.bmc.2012.05.045 Document Type: Article |
Times cited : (18)
|
References (33)
|